Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
V. Castronovo, N. Canessa, F. Alemanno, A. Falini, L. Ferini Strambi, S. Cappa (Milan, Italy). Cerebral grey matter changes in obstructive sleep apnoea (OSA). Eur Respir J 2009; 34: Suppl. 53, 2827

Member's Comments

ROCHE Frederic - 15.09.2009 09:54
another recent paper on topic
S. Celle et coll had report no significant impact on cortical GM volume but focal brainstem alerations in an elderly asymptomatic population ( Human Brain Map. 2009)

Related content which might interest you: Changes in white matter integrity in obstructive sleep apnea (OSA) patients after CPAP treatment Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Effect of obstructive sleep apnea syndrome (OSAS) on cognitive performances Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Obstructive sleep apnea (OSA) in young and elderly patients – does age matter? Source: Eur Respir J 2006; 28: Suppl. 50, 200s Year: 2006 Predictors of hypercapnia in obstructive sleep apnoea (OSA) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010 Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007 Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Hyperuricaemia in females with obstructive sleep apnoea (OSA) Source: Eur Respir J 2003; 22: Suppl. 45, 91s Year: 2003 Hyperuricaemia in males with obstructive sleep apnoea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006 The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA) Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Does PAP treatment in obstructive sleep apnea (OSA) patients change functional MRI activation? Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Erythrocyte glycolysis in severe obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 354s Year: 2005 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Obstructive sleep apnea syndrome (OSAS). Value of cardiovascular markers (CM) to detect arousals Source: Eur Respir J 2003; 22: Suppl. 45, 272s Year: 2003